Related references
Note: Only part of the references are listed.Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction
Hayley McDonald et al.
PHYSIOLOGICAL REPORTS (2018)
Mechanisms of Lung Fibrosis Resolution
Stephan W. Glasser et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
Moises Selman et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Effects of Fibrotic Tissue on Liver-targeted Hydrodynamic Gene Delivery
Yuji Kobayashi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Impairment of autophagosome-lysosome fusion in the buff mutant mice with the VPS33AD251E mutation
Yuanli Zhen et al.
AUTOPHAGY (2015)
Interstitial Collagen Catabolism
Gregg B. Fields
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis
Roger Hesselstrand et al.
RESPIRATORY MEDICINE (2013)
Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16
Amanda E. Starr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis
Cory M. Yamashita et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Matrix Metalloproteinase-13 Promotes Recovery from Experimental Liver Cirrhosis in Rats
Hitoshi Endo et al.
PATHOBIOLOGY (2011)
LOSS OF MATRIX METALLOPROTEINASE-13 ATTENUATES MURINE RADIATION-INDUCED PULMONARY FIBROSIS
Paul Flechsig et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Loss of MMP 13 attenuates murine hepatic injury and fibrosis during Cholestasis
Hiroshi Uchinami et al.
HEPATOLOGY (2006)
Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis
A Pardo et al.
PLOS MEDICINE (2005)
Share Paper
